Human UDP-Glucuronosyltransferase (UGT) 2B10: Validation of Cotinine as a Selective Probe Substrate, Inhibition by UGT Enzyme-Selective Inhibitors and Antidepressant and Antipsychotic Drugs, and Structural Determinants of Enzyme Inhibition

被引:25
|
作者
Pattanawongsa, Attarat [1 ,2 ]
Nair, Pramod C. [1 ,2 ]
Rowland, Andrew [1 ]
Miners, John O. [1 ,2 ]
机构
[1] Flinders Univ S Australia, Sch Med, Dept Clin Pharmacol, GPO Box 2100, Adelaide, SA 5001, Australia
[2] Flinders Univ S Australia, Sch Med, Flinders Ctr Innovat Canc, Adelaide, SA 5001, Australia
关键词
HUMAN LIVER-MICROSOMES; IN-VIVO EXTRAPOLATION; BOVINE SERUM-ALBUMIN; N-GLUCURONIDATION; DEPRESSED-PATIENTS; HUMAN UGT2B10; VITRO DATA; NICOTINE; KINETICS; 2B7;
D O I
10.1124/dmd.115.068213
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Although there is evidence for an important role of UGT2B10 in the N-glucuronidation of drugs and other xenobiotics, the inhibitor selectivity of this enzyme is poorly understood. This study sought primarily to characterize the inhibition selectivity of UGT2B10 by UDP-glucuronosyltransferase (UGT) enzyme-selective inhibitors used for reaction phenotyping, and 34 antidepressant and antipsychotic drugs that contain an amine functional group. Initial studies demonstrated that cotinine is a highly selective substrate of human liver microsomal UGT2B10. The kinetics of cotinine N-glucuronidation by recombinant UGT and human liver microsomes (6 bovine serum albumin) were consistent with the involvement of a single enzyme. Of the UGT enzyme-selective inhibitors employed for reaction phenotyping, only the UGT2B4/7 inhibitor fluconazole reduced recombinant UGT2B10 activity to an appreciable extent. The majority of antidepressant and antipsychotic drugs screened for effects on UGT2B10 inhibited enzyme activity with IC50 values <100 mu M. The most potent inhibition was observed with the tricyclic antidepressants amitriptyline and doxepin and the tetracyclic antidepressant mianserin, and the structurally related compounds desloratadine and loratadine. Molecular modeling using a ligand-based approach indicated that hydrophobic and charge interactions are involved in inhibitor binding, whereas spatial features influence the potency of UGT2B10 inhibition. Respective mean K-i,K-u (+/- S. D.) values for amitriptyline, doxepin, and mianserin inhibition of human liver microsomal UGT2B10 were 0.61 +/- 0.05, 0.95 +/- 0.18, and 0.43 +/- 0.01 mM. In vitro-in vivo extrapolation indicates that these drugs may perpetrate inhibitory drug-drug interactions when coadministered with compounds that are cleared predominantly by UGT2B10.
引用
收藏
页码:378 / 388
页数:11
相关论文
共 11 条
  • [1] Probe substrate and enzyme source-dependent inhibition of UDP-glucuronosyltransferase (UGT) 1A9 by wogonin
    Gao, Chengcheng
    Xie, Rui
    Ma, Tianheng
    Yan, Wei
    Pang, Liqun
    AFRICAN HEALTH SCIENCES, 2013, 13 (03) : 551 - 555
  • [2] Human UDP-Glucuronosyltransferase (UGT) 2B10 in Drug N-Glucuronidation: Substrate Screening and Comparison with UGT1A3 and UGT1A4
    Kato, Yukiko
    Izukawa, Takeshi
    Oda, Shingo
    Fukami, Tatsuki
    Finel, Moshe
    Yokoi, Tsuyoshi
    Nakajima, Miki
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (07) : 1389 - 1397
  • [3] Inhibition of cell proliferation mediated by human UDP-glucuronosyltransferase 2B7 (UGT2B7).
    Czernik, PJ
    Santin, AD
    Pokrovskaya, ID
    Xu, J
    Little, JM
    Radominska-Pandya, A
    FASEB JOURNAL, 2002, 16 (04): : A561 - A561
  • [4] Highly selective N-glucuronidation of four piperazine-containing drugs by UDP-glucuronosyltransferase 2B10
    Lu, Danyi
    Dong, Dong
    Wu, Baojian
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2018, 14 (09) : 989 - 998
  • [5] In vitro selective inhibition of human UDP-glucuronosyltransferase (UGT) 1A4 by finasteride, and prediction of in vivo drug-drug interactions
    Lee, Seung Jun
    Park, Jung Bae
    Kim, Doyun
    Bae, Soo Hyeon
    Chin, Young-Won
    Oh, Euichaul
    Bae, Soo Kyung
    TOXICOLOGY LETTERS, 2015, 232 (02) : 458 - 465
  • [6] Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and clinical significance
    Miners, John O.
    Polasek, Thomas M.
    Hulin, Julie-Ann
    Rowland, Andrew
    Meech, Robyn
    PHARMACOLOGY & THERAPEUTICS, 2023, 248
  • [7] A highly selective probe for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human microsomes: isoform specificity, kinetic characterization, and applications
    Tian, Xiang-Ge
    Wang, Chao
    Ge, Guang-Bo
    Ning, Jing
    Ai, Chun-Zhi
    Hong, James Y.
    Cai, Yong-Xv
    Huo, Xiao-Kui
    Hou, Jie
    Liu, Ke-Xin
    Sun, Hong-Zhi
    Ma, Xiao-Chi
    RSC ADVANCES, 2015, 5 (08) : 5924 - 5927
  • [8] Isoform-selective inhibition of the human UDP-glucuronosyltransferase 2B7 by isolongifolol derivatives
    Bichlmaier, Ingo
    Kurkela, Mika
    Joshi, Tanmaya
    Siiskonen, Antti
    Rueffer, Tobias
    Lang, Heinrich
    Suchanova, Bohumila
    Vahermo, Mikko
    Finel, Moshe
    Yli-Kauhaluoma, Jari
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (11) : 2655 - 2664
  • [9] Further Characterization of the Metabolism of Desloratadine and Its Cytochrome P450 and UDP-glucuronosyltransferase Inhibition Potential: Identification of Desloratadine as a Relatively Selective UGT2B10 Inhibitor
    Kazmi, Faraz
    Yerino, Phyllis
    Barbara, Joanna E.
    Parkinson, Andrew
    DRUG METABOLISM AND DISPOSITION, 2015, 43 (09) : 1294 - 1302
  • [10] Enantiomer Selective Glucuronidation of the Non-Steroidal Pure Anti-Androgen Bicalutamide by Human Liver and Kidney: Role of the Human UDP-Glucuronosyltransferase (UGT)1A9 Enzyme
    Grosse, Laurent
    Campeau, Anne-Sophie
    Caron, Sarah
    Morin, Frederic-Alexandre
    Meunier, Kim
    Trottier, Jocelyn
    Caron, Patrick
    Verreault, Melanie
    Barbier, Olivier
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2013, 113 (02) : 92 - 102